VISTA, on the other hand, can act as a ligand when expressed on the surface of APCs and, more importantly, as a receptor when presented on the surface of T cells (TILs included); the binding partner(s) of VISTA expressed on tumor cells are still not fully identified [42,43,44,45,46]. This evidence concerns the gene VSIR and neoplasm.